Evaluation of Ceftaroline Activity against Heteroresistant Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Intermediate Methicillin-Resistant S. aureus Strains in anIn VitroPharmacokinetic/Pharmacodynamic Model: Exploring the “Seesaw Effect”

Brian J. Werth, Molly E. Steed, Glenn W. Kaatz, Michael J. Rybak
  • Antimicrobial Agents and Chemotherapy, April 2013, ASM Journals
  • DOI: 10.1128/aac.02308-12

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Michael J. Rybak

In partnership with: